19 June 2013
Keywords: chiron, looking, flat, after, betaseron, high, becoming
Article | 11 April 1994
After becoming one of the few biotechnology companies with a net income, Chiron shares have now fallen more than 30% since ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.